Unaudited Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Sale of product	$ 3,277,816	$ 3,924,444	$ 10,172,036	$ 9,998,135
Cost of product	1,337,797	1,475,016	4,058,421	3,665,085
Gross profit	1,940,019	2,449,428	6,113,615	6,333,050
Operating costs and expenses:
Salaries and contract labor	1,160,434	1,074,535	3,368,592	2,976,880
General, administrative, and consulting	821,588	1,082,937	2,777,519	3,133,557
Research and development	139,411	112,351	348,775	489,328
Total operating expenses	2,121,433	2,269,823	6,494,886	6,599,765
Net operating (loss) income	(181,414)	179,605	(381,271)	(266,715)
Other income (expense):
Other income	44,114	20,718	96,558	176,094
Interest income	19,984	31,812	60,576	98,071
Interest expense	(86,285)	(81,884)	(252,943)	(244,695)
Total other (expense) income	(22,187)	(29,354)	(95,809)	29,470
Net (loss) income	$ (203,601)	$ 150,251	$ (477,080)	$ (237,245)
Net loss (income) per common share - basic: (in dollars per share)	$ 0	$ 0	$ 0	$ 0
Net loss (income) per common share - diluted: (in dollars per share)	$ 0	$ 0	$ 0	$ 0
Weighted average common shares outstanding - basic (in shares)	528,088,472	523,138,891	526,568,064	522,028,572
Weighted average common shares outstanding - diluted (in shares)	528,088,472	523,138,891	526,568,064	522,028,572